Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review

Front Pharmacol. 2021 Oct 25:12:770125. doi: 10.3389/fphar.2021.770125. eCollection 2021.

Zhi-Hua Yang^{1

2}, Bin Wang², Qian Ma^{1

2}, Lin Wang^{1

2}, Ya-Xin Lin², Hai-Feng Yan^{1

2}, Zi-Xuan Fan^{1

2}, Hao-Jia Chen^{1

2}, Zhao Ge^{1

2}, Feng Zhu³, Hui-Jie Wang⁴, Bao-Nan Zhang⁴, Hai-Dong Sun^{5

6}, Li-Min Feng⁷

¹ First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
² Tianjin University of Traditional Chinese Medicine, Tianjin, China.
³ Department of Traditional Chinese Medicine, Hebei North University, Zhangjiakou, China.
⁴ Department of Cardiology, Traditional Chinese Medicine Hospital of Tianjin Beichen District, Tianjin, China.
⁵ Tianjin Fourth Central Hospital, Tianjin, China.
⁶ Shenzhen Hospital Futian of Guangzhou University of Chinese Medicine, Shenzhen, China.
⁷ Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.668407.].

Keywords: COVID-19; Chinese patent medicines; SARS-CoV-2; review; traditional Chinese medicines.